Elsevier

The Lancet

Volume 376, Issue 9750, 23–29 October 2010, Pages 1372-1373
The Lancet

Comment
Huntington's disease out of the closet?

https://doi.org/10.1016/S0140-6736(10)60974-9Get rights and content

References (5)

  • A Wexler

    Stigma, history, and Huntington's disease

    Lancet

    (2010)
  • PS Harper

    The epidemiology of Huntington's disease

There are more references available in the full text version of this article.

Cited by (48)

  • Regulatory roles of the miR-200 family in neurodegenerative diseases

    2019, Biomedicine and Pharmacotherapy
    Citation Excerpt :

    The miR-200 family may participate in the pathogenesis of ALS through regulating many molecular circuits, which needs to be clarified to develop new therapeutic strategies. Huntington's disease (HD) is a genetic neurodegenerative disease, which affects approximately 6–7 per 100 000 people in the United Kingdom, but the true prevalence may be greater [84]. HD is caused by abnormal expanded Cytosine-Adenine-Guanine (CAG) repeats in the gene encoding protein Huntingtin (HTT) [85].

  • Huntington disease

    2018, Handbook of Clinical Neurology
    Citation Excerpt :

    The prevalence of HD varies across the globe. In Western and European populations, it has typically been quoted at around 4–10/100,000 people (Harper, 2002); however, a more recent study from the United Kingdom suggests it may be closer to 12.3/100,000 population (Rawlins, 2010; Evans et al., 2013). This makes it among the more common of the inherited neurologic diseases.

  • Dysregulation of system x<inf>c</inf><sup>-</sup> expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice

    2014, Neurochemistry International
    Citation Excerpt :

    Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease caused by an expansion of the CAG region in exon 1 of the huntingtin gene (htt) (The Huntington’s Disease Collaborative Research Group, 1993) affecting approximately 10 in 100,000 people (Rawlins, 2010).

  • Epigenetic modifications in trinucleotide repeat diseases

    2013, Trends in Molecular Medicine
    Citation Excerpt :

    It is clear, however, that differential DNA methylation in regions flanking the TNR in DMPK, particularly in different tissues, is likely to be an important contributing factor to the variable clinical outcome of this disease. HD is the most common TNR-associated disease with a prevalence estimated at 12.4 per 100 000 [89,90]. HD is an autosomal dominant, progressive neurodegenerative disorder which can result in involuntary movements (chorea), dementia, and, in some affected individuals, psychiatric symptoms.

  • Heuristic Approach to Curate Disease Taxonomy Beyond Nosology-Based Standards

    2023, Communications in Computer and Information Science
View all citing articles on Scopus
View full text